A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)Michel Michaelides, Philip Hykin, Andrew Kaines et al.|Ophthalmology|2010Cited by 510
Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service SettingNamritha Patrao, Ranjan Rajendram, Philip Hykin et al.|American Journal of Ophthalmology|2016Cited by 86
Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeabilitySwaantje Peters, Stephen E. Moss, Ian A. Cree et al.|Cytokine|2007Cited by 80
Intravitreal aflibercept for diabetic macular oedema: Moorfields’ real-world 12-month visual acuity and anatomical outcomesMarko Lukić, Ranjan Rajendram, Gwyn Samuel Williams et al.|European Journal of Ophthalmology|2019Cited by 35
Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomesMarko Lukić, Ranjan Rajendram, Gwyn Samuel Williams et al.|European Journal of Ophthalmology|2020Cited by 29